carbolightplan.org
A scientific and visionary approach to meal planning
Author: Barbara E. Corkey was the Zoltan Kohn Professor of Medicine and Vice Chair for Research in the Department of Medicine at Boston University and is currently an Emeritus Professor. She has been a leader in the fields of diabetes and obesity research that encompasses over 50 years yielding 200 publications through 40 years of continuous government research support. The Corkey laboratory has been engaged in research at the cell level particularly the metabolic signaling among insulin producing ß-cells, adipose tissue and liver cells. Recent work into the cause of Type 2 diabetes has focused on intercellular communication via circulating redox and the role of hyperinsulinemia in obesity and diabetes. Projects in metabolic regulation have been ongoing since 1981. A current major focus is on developing clinical/basic collaborative projects to explore novel approaches to promote Culinary Medicine in order to understand and treat metabolic diseases. In recognition she has received numerous honors including the NIH MERIT Award, National Honorary Membership in Iota Sigma Pi, the National Honor Society of Women in Chemistry, Women in Science Lecturer at the Boston Museum of Science, the George Bray Founders Award of the Obesity Society, the Charles H. Best Lectureship and Award, University of Toronto and the Banting Medal for Scientific Achievement from the American Diabetes Association.
Goal: The Carbolight Plan is designed to improve metabolic health, to prevent development of diabetes and cardiovascular disease, and reverse diabetes, fatty liver and other metabolic abnormalities. The plan focuses on meals that are delicious, flavorful and easy to prepare.
Diseases: The causes of metabolic disease are not known and there are no known cures. Not surprisingly, the number of individuals suffering from these diseases continues to increase and the inclination to blame the patients for their diseases, which the medical profession cannot explain, continues to undermine essential research. Patients with metabolic disease frequently have high fasting insulin, central obesity (high waist to hip ratio), elevated blood and tissue lipids: too much fasting insulin and too much fat in sensitive locations like liver, blood vessels and pancreas. Metabolic diseases that have these features include central obesity, metabolic syndrome, prediabetes, type 2 diabetes, fatty liver (NAFLD), NASH, polycystic ovary syndrome (PCOS) and some cardiovascular diseases. There is increasing scientific evidence that decreasing fasting insulin and abnormal fat stores can improve these diseases. This eating plan is designed to lower fasting insulin and lipids stored in the wrong places. It can lead in many cases to sustained reversal of disease and prevention of worsening disease.
Author: Barbara E. Corkey was the Zoltan Kohn Professor of Medicine and Vice Chair for Research in the Department of Medicine at Boston University and is currently an Emeritus Professor. She has been a leader in the fields of diabetes and obesity research that encompasses over 50 years yielding 200 publications through 40 years of continuous government research support. The Corkey laboratory has been engaged in research at the cell level particularly the metabolic signaling among insulin producing ß-cells, adipose tissue and liver cells. Recent work into the cause of Type 2 diabetes has focused on intercellular communication via circulating redox and the role of hyperinsulinemia in obesity and diabetes. Projects in metabolic regulation have been ongoing since 1981. A current major focus is on developing clinical/basic collaborative projects to explore novel approaches to promote Culinary Medicine in order to understand and treat metabolic diseases. In recognition she has received numerous honors including the NIH MERIT Award, National Honorary Membership in Iota Sigma Pi, the National Honor Society of Women in Chemistry, Women in Science Lecturer at the Boston Museum of Science, the George Bray Founders Award of the Obesity Society, the Charles H. Best Lectureship and Award, University of Toronto and the Banting Medal for Scientific Achievement from the American Diabetes Association.
Goal: The Carbolight Plan is designed to improve metabolic health, to prevent development of diabetes and cardiovascular disease, and reverse diabetes, fatty liver and other metabolic abnormalities. The plan focuses on meals that are delicious, flavorful and easy to prepare.
Diseases: The causes of metabolic disease are not known and there are no known cures. Not surprisingly, the number of individuals suffering from these diseases continues to increase and the inclination to blame the patients for their diseases, which the medical profession cannot explain, continues to undermine essential research. Patients with metabolic disease frequently have high fasting insulin, central obesity (high waist to hip ratio), elevated blood and tissue lipids: too much fasting insulin and too much fat in sensitive locations like liver, blood vessels and pancreas. Metabolic diseases that have these features include central obesity, metabolic syndrome, prediabetes, type 2 diabetes, fatty liver (NAFLD), NASH, polycystic ovary syndrome (PCOS) and some cardiovascular diseases. There is increasing scientific evidence that decreasing fasting insulin and abnormal fat stores can improve these diseases. This eating plan is designed to lower fasting insulin and lipids stored in the wrong places. It can lead in many cases to sustained reversal of disease and prevention of worsening disease.